Qilu Pharmaceutical Co.  Ltd.

Qilu Pharmaceutical Co. Ltd.


Company description

Qilu Pharmaceutical, one of the leading pharmaceutical companies in China, develops, manufactures and markets quality and affordable generic drugs in some important therapeutic areas of Oncology, Infections, Cerebrovascular & Cardiovascular, Psychological and Neurological system, Respiratory system, and Ophthalmological Diseases. With strong R&D capability, the company developed and launched lots of branded generics in the last two decades, most of which are well-known with a high recognition among general public. A rich and expanding pipeline is integrated into the product portfolio that is the drive for steady and rapid growth of the company. Besides a prosperous domestic market, Qilu is also actively registering its products with Drug Master File and Dossier in many countries. In response to increasing interest in products of China origin, the company is ready to provide Custom Manufacture for the customers with not only cost savings but also high quality. The combination of technical know-how, state-of-the-art production facilities and integrated regulatory support provided by Qilu will be critical advantages for its customers in present competitive environment.

Quick facts

Sales markets Western Europe; Eastern Europe; Asia; North America; Central/South America
Primary business activity Manufacturer
Affiliated categories: API Contract Manufacturing |Pharmaceutical Technology (general category) |Biopharmaceuticals More

Upcoming events

13 oct 2020

CPhI Worldwide 2020

13 - 15 October 2020 Milan, Italy Visit us at stand 18J40 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 40H30 See our Exhibitor Profile   See full Exhibitor List
18 mar 2019

CPhI Japan 2019

18 - 20 March 2019 Tokyo, Japan We were at stand 3D-25 See our Exhibitor Profile   See full Exhibitor List
Qilu Pharmaceutical Co. Ltd.

Contact information




View all contact information